EMMPRIN/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression

Fibroblast Growth Factor Receptor Mediates Fibroblast-Dependent Growth in EMMPRIN-Depleted Head and Neck Cancer Tumor Cells

(2011) Z. Liu et al.   MOLECULAR CANCER RESEARCH

Advances in the systemic treatment of head and neck cancers

(2010) Pol Specenier et al.   CURRENT OPINION IN ONCOLOGY

CD147/basigin promotes progression of malignant melanoma and other cancers

(2010) Takuro Kanekura et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Urinary-Type Plasminogen Activator Receptor/ 3 1 Integrin Signaling, Altered Gene Expression, and Oral Tumor Progression

(2010) S. Ghosh et al.   MOLECULAR CANCER RESEARCH

Head and Neck Squamous Cell Carcinoma: New Translational Therapies

(2010) Anthony Prince et al.   MOUNT SINAI JOURNAL OF MEDICINE

EMMPRIN Promotes Melanoma Cells Malignant Properties through a HIF-2alpha Mediated Up-Regulation of VEGF-Receptor-2

(2010) Faten Bougatef et al.   PLoS One

Laminin-derived peptide AG73 regulates migration, invasion, and protease activity of human oral squamous cell carcinoma cells through syndecan-1 and β1 integrin

(2010) Adriane S. Siqueira et al.   TUMOR BIOLOGY

EMMPRIN promotes angiogenesis through hypoxia-inducible factor-2 -mediated regulation of soluble VEGF isoforms and their receptor VEGFR-2

(2009) F. Bougatef et al.   BLOOD

Modulation of Tumor Cell Growth In Vivo by Extracellular Matrix Metalloprotease Inducer

(2008) J. Robert Newman et al.   ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY

Role of Emmprin/CD147 in Tissue Remodeling

(2008) Eric Huet et al.   CONNECTIVE TISSUE RESEARCH

Hyaluronan, CD44 and Emmprin: Partners in cancer cell chemoresistance

(2008) Bryan P. Toole et al.   DRUG RESISTANCE UPDATES